Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study (Q34608501)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
scientific article

    Statements

    Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study (English)
    Donna E Reece
    Vaishali Sanchorawala
    Ute Hegenbart
    Giovanni Palladini
    Jean-Paul Fermand
    Robert A Vescio
    Xiangyang Liu
    Yusri A Elsayed
    Andrew Cakana
    Raymond L Comenzo
    VELCADE CAN2007 Study Group
    1489-1497

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit